Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Short-Term Debt repayments

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Loans and Notes Receivables Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments R&D In Process Receivables - Net Shares Outstanding Shares Outstanding Short-Term Debt repayments

Odyssey Health (ODYY) Shares Issued (2020 - 2021)

Odyssey Health has reported Shares Issued over the past 2 years, most recently at -$216753.0 for Q3 2021.

For Q3 2021, Shares Issued changed N/A year-over-year to -$216753.0; the TTM value through Jul 2021 reached $2.5 million, changed N/A, while the annual FY2024 figure was $55620.0, 90.41% down from the prior year.
Shares Issued for Q3 2021 was -$216753.0 at Odyssey Health, down from $2.4 million in the prior quarter.
Over five years, Shares Issued peaked at $2.4 million in Q2 2021 and troughed at -$216753.0 in Q3 2021.